ArticleCancer immunology research2015

Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury.

Christopher R Heery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.